Insufficient scRNA-seq data for expression of EPOP at single-cell level.
Insufficient scRNA-seq data for expression of EPOP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 95% | 277.70 | 232 / 245 | 95% | 8.57 | 476 / 502 |
brain | 94% | 712.67 | 2495 / 2642 | 95% | 17.73 | 670 / 705 |
skin | 98% | 489.33 | 1777 / 1809 | 89% | 8.97 | 421 / 472 |
bladder | 90% | 157.48 | 19 / 21 | 97% | 21.71 | 487 / 504 |
esophagus | 91% | 238.26 | 1309 / 1445 | 94% | 13.91 | 172 / 183 |
lung | 92% | 199.97 | 532 / 578 | 86% | 11.02 | 996 / 1155 |
stomach | 88% | 185.38 | 317 / 359 | 88% | 13.29 | 252 / 286 |
pancreas | 100% | 320.00 | 328 / 328 | 76% | 6.40 | 136 / 178 |
uterus | 85% | 162.16 | 144 / 170 | 91% | 14.97 | 416 / 459 |
breast | 95% | 217.46 | 436 / 459 | 78% | 10.19 | 874 / 1118 |
ovary | 78% | 129.09 | 140 / 180 | 89% | 15.18 | 382 / 430 |
intestine | 74% | 131.54 | 713 / 966 | 91% | 16.27 | 479 / 527 |
liver | 98% | 356.23 | 221 / 226 | 62% | 6.64 | 253 / 406 |
adrenal gland | 100% | 366.71 | 257 / 258 | 58% | 5.06 | 133 / 230 |
thymus | 81% | 123.50 | 528 / 653 | 68% | 5.12 | 414 / 605 |
kidney | 75% | 129.31 | 67 / 89 | 43% | 2.49 | 390 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 41.49 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 51.01 | 1 / 1 |
spleen | 96% | 209.45 | 232 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 10.56 | 76 / 80 |
tonsil | 0% | 0 | 0 / 0 | 89% | 9.80 | 40 / 45 |
adipose | 85% | 219.99 | 1022 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 70% | 114.61 | 930 / 1335 | 0% | 0 | 0 / 0 |
heart | 59% | 101.58 | 506 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 27% | 280.97 | 249 / 929 | 0% | 0 | 0 / 0 |
muscle | 14% | 35.11 | 114 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048863 | Biological process | stem cell differentiation |
GO_0140673 | Biological process | transcription elongation-coupled chromatin remodeling |
GO_0048663 | Biological process | neuron fate commitment |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0035098 | Cellular component | ESC/E(Z) complex |
GO_0005694 | Cellular component | chromosome |
GO_0070449 | Cellular component | elongin complex |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | EPOP |
Protein name | Elongin BC and Polycomb repressive complex 2-associated protein (Proline-rich protein 28) |
Synonyms | C17orf96 PRR28 |
Description | FUNCTION: Scaffold protein that serves as a bridging partner between the PRC2/EZH2 complex and the elongin BC complex: required to fine-tune the transcriptional status of Polycomb group (PcG) target genes in embryonic stem cells (ESCs). Plays a key role in genomic regions that display both active and repressive chromatin properties in pluripotent stem cells by sustaining low level expression at PcG target genes: acts by recruiting the elongin BC complex, thereby restricting excessive activity of the PRC2/EZH2 complex. Interaction with USP7 promotes deubiquitination of H2B at promoter sites. Acts as a regulator of neuronal differentiation. . |
Accessions | A6NHQ4 ENST00000613024.2 ENST00000621654.2 |